CHARACTERISTIC FEATURES OF THE COMORBID COURSE OF ALCOHOLISM AND SCHIZOAFFECTIVE DISORDERS

Sedenkov Vitaly Sergeevich; Sultanov Shoxrux Xabibullayevich; Turayev Bobir Temirpulotovich

doi:10.61796/jmgcb.v2i1.1205

Authors

Sedenkov Vitaly Sergeevich
sedenkov@gmail.com
Ural State Medical University, Russian Federation
Sultanov Shoxrux Xabibullayevich Tashkent State Dental Institute, Uzbekistan
Turayev Bobir Temirpulotovich Samarkand State Medical University, Uzbekistan

Vol. 2 No. 1 (2025): Journal of Medical Genetics and Clinical Biology

Articles

January 15, 2025

Downloads

View Article

Abstract
How to Cite
Metrics
References
License

Objective: This study aims to investigate the characteristic features of the comorbid course of alcoholism and schizoaffective disorders, focusing on the interplay between neurobiological mechanisms and clinical outcomes in patients with dual diagnoses. Method: A comprehensive review of clinical data and neurobiological studies was conducted, analyzing treatment approaches and the convergence of pathophysiological processes in patients with co-occurring alcohol dependence and schizoaffective disorders. Particular attention was given to the role of the dynorphin kappa-opioid system as a modulator of mesocorticolimbic dopaminergic system activity, which is implicated in both mental disorders and substance addiction. Results: The findings indicate that comorbid patients exhibit more severe clinical symptoms, poorer prognoses, and reduced treatment efficacy compared to individuals with singular diagnoses. The dysregulation of the dynorphin kappa-opioid system contributes to the exacerbation of both psychotic and addictive symptoms, complicating therapeutic interventions. Novelty: This study highlights the critical role of the dynorphin kappa-opioid system as a universal modulator in the pathogenesis of schizoaffective disorders and alcoholism, emphasizing the need for integrated treatment strategies that target both neurobiological and clinical dimensions of comorbidity.

Vitaly Sergeevich, S., Shoxrux Xabibullayevich, S., & Bobir Temirpulotovich, T. (2025). CHARACTERISTIC FEATURES OF THE COMORBID COURSE OF ALCOHOLISM AND SCHIZOAFFECTIVE DISORDERS. Journal of Medical Genetics and Clinical Biology, 2(1), 127–135. https://doi.org/10.61796/jmgcb.v2i1.1205

Download Citation

Yu. V Zhitkova, “Morphofunctional bases for the development of vascular cognitive and emotional disorders,” Neurology, Neuropsychiatry, Psychosomatics, vol. 9, no. 2, pp. 40–45, Jan. 2017, doi: 10.14412/2074-2711-2017-2-40-45.

A. Anca-Laura, “Peculiarities Regarding Creativity in Paranoid Schizophrenia,” Procedia Soc Behav Sci, vol. 127, pp. 454–458, Apr. 2014, doi: 10.1016/j.sbspro.2014.03.289.

A. Matthews, R. A. Kramer, and L. Mitan, “Eating Disorder Severity and Psychological Morbidity in Adolescents with Anorexia Nervosa or Atypical Anorexia Nervosa and Premorbid Overweight/Obesity,” Feb. 2021, doi: 10.21203/rs.3.rs-210417/v1.

R. T. Vieira, “Epidemiology of early-onset dementia: a review of the literature,” Clinical Practice & Epidemiology in Mental Health, vol. 9, no. 1, pp. 88–95, Jul. 2013, doi: 10.2174/1745017901309010088.

C. Guerri, “Neuroanatomical and Neurophysiological Mechanisms Involved in Central Nervous System Dysfunctions Induced by Prenatal Alcohol Exposure,” Alcoholism: Clinical & Experimental Research, vol. 22, no. 2, p. 15, Apr. 1998, doi: 10.1097/00000374-199804000-00003.

G. Vittadini, “ALCOHOLIC POLYNEUROPATHY: A CLINICAL AND EPIDEMIOLOGICAL STUDY,” Alcohol and Alcoholism, vol. 36, no. 5, pp. 393–400, Sep. 2001, doi: 10.1093/alcalc/36.5.393.

T. Nefedova, “Efficacy of Psychotherapeutic Interventions in the Treatment of Breast Cancer Patients,” Collection of Research Papers “Problems of Modern Psychology,” pp. 156–182, Dec. 2022, doi: 10.32626/2227-6246.2022-58.156-182.

N. A. Tsalikova and A. T. Manukyan, “The effectiveness of the use of adaptogenic drugs for adaptation of patients with depressive neurosis to fixed orthopedic prosthetics.,” Stomatology for All / International Dental review, no. 1(110), pp. 54–57, Mar. 2025, doi: 10.35556/idr-2025-1(110)54-57.

V. N. Shishkova, “Psycho-emotional state of patients with chronic non-communicable diseases: important aspects of therapy,” Meditsinskiy sovet = Medical Council, no. 13, pp. 256–262, Aug. 2023, doi: 10.21518/ms2023-230.

M. Ehsani, N. Seyedfatemi, S. Haghani, and A. Abbasi, “Anxiety, Depression, and Post-traumatic Stress Disorder Symptoms in Patients Treated With Immunosuppressive Drugs During the COVID-19 Pandemic,” Iran Journal of Nursing, vol. 36, no. 144, pp. 424–437, Oct. 2023, doi: 10.32598/ijn.36.144.3354.

S. P Veeramuthu and M. L. A. Rahman, “Students’ Perceptions of Online Teaching and Learning in Literature Studies at University during COVID-19 Pandemic,” in COVID-19 Pandemic Challenges and Innovations, Innovare Academic Sciences Pvt Ltd, 2023. doi: 10.22159/covid19.c7.

R. A. Al-Eryani and L. A. Al- Najjar, “Assessment of Salivary Immunoglobulin a and Lysozyme Levels and Their Relation to Dental Caries Status in a Group of Yemeni Asthmatic Children,” Saudi Journal of Oral and Dental Research, vol. 10, no. 01, pp. 43–51, Jan. 2025, doi: 10.36348/sjodr.2025.v10i01.007.

M. Pontillo, D. Menghini, and S. Vicari, “Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal study,” Schizophr Res, vol. 208, pp. 76–81, Jun. 2019, doi: 10.1016/j.schres.2019.04.012.

A. Ferbert and K. Willmes, “The Relevance of Neurological and Functional Outcome Scales for Acute Stroke Trials,” in Thrombolytic Therapy in Acute Ischemic Stroke II, Springer Berlin Heidelberg, 1993, pp. 217–223. doi: 10.1007/978-3-642-78061-5_31.

Y. Okada, K. Inada, and M. Akazawa, “Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan,” Schizophr Res, vol. 252, pp. 300–308, Feb. 2023, doi: 10.1016/j.schres.2023.01.019.

R. B. Seedall and J. C. Anthony, “Risk estimates for starting tobacco, alcohol, and other drug use in the United States: Male–female differences and the possibility that ‘limiting time with friends’ is protective,” Drug Alcohol Depend, vol. 133, no. 2, pp. 751–753, Dec. 2013, doi: 10.1016/j.drugalcdep.2013.06.035.

Y. Park, S. Park, and M. Lee, “Effectiveness of artificial intelligence in detecting and managing depressive disorders: Systematic review,” J Affect Disord, vol. 361, pp. 445–456, Sep. 2024, doi: 10.1016/j.jad.2024.06.035.

C. A. Benson, “Reply,” Clinical Infectious Diseases, vol. 18, no. 1, p. 129, Jan. 1994, doi: 10.1093/clinids/18.1.129.

G. Shealy, “Dementia Case Management: Variances and Clinical Pathways for Dementia Case Management,” Prof Case Manag, vol. 27, no. 3, pp. 161–165, May 2022, doi: 10.1097/ncm.0000000000000571.

P. Chassagne and S. N’Guyen, “Hydratation et natrémie,” in Gériatrie, Elsevier, 2023, pp. 356–360. doi: 10.1016/b978-2-294-77815-5.00039-1.

C. S. Copeland, “Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk,” Addiction, Jan. 2025, doi: 10.1111/add.16777.

J. D. Rawat and S. Singh, “Disorder of Testicular Development,” in Children with Differences in Sex Development, Springer Nature Singapore, 2024, pp. 245–251. doi: 10.1007/978-981-97-1639-5_22.

N. A. Bokhan, G. Yu. Selivanov, A. A. Salnikov, and K. A. Blonsky, “WITHDRAWAL SYNDROME IN SYNTHETIC CANNABINOID DEPENDENCE ASSOCIATED WITH MENTAL DISORDERS,” Вопросы наркологии, no. 12, pp. 5–18, 2020, doi: 10.47877/0234-0623_2020_12_5.

R. W. Lam, “Clinical features and diagnosis,” in Depression, Oxford University Press, 2018, pp. 23–34. doi: 10.1093/med/9780198804147.003.0004.

D. Ranđelović, “The Co-occurrence of Non-suicidal Self-injury and Attempted Suicide Among Adolescents Hospitalized in Clinic for Mental Disorders ‘Dr Laza Lazarevic,’” Feb. 2017, doi: 10.26226/morressier.588f064fd462b8028d891e2c.

M. Carmona-Perera, G. A. del Paso, M. Pérez-García, and A. Verdejo-García, “Heart rate correlates of utilitarian moral decision-making in alcoholism,” Drug Alcohol Depend, vol. 133, no. 2, pp. 413–419, Dec. 2013, doi: 10.1016/j.drugalcdep.2013.06.023.

I. Belokrylov, “The Effectiveness of Psychoanalytic Psychotherapy in the Somatoform Disorders Treatment,” Feb. 2018, doi: 10.26226/morressier.5a7070ded462b80290b56a4a.

E. Alleyne and J. L. Wood, “Gang involvement: psychological and behavioral characteristics of gang members, peripheral youth, and nongang Youth,” Aggress Behav, vol. 36, no. 6, pp. 423–436, Aug. 2010, doi: 10.1002/ab.20360.

L. S. Namasova-Baranova et al., “RESTORATIVE TREATMENT OF ORTHOPEDIC PATIENTS IN A MODERN REHABILITATION CENTER,” Pediatric pharmacology, vol. 9, no. 3, p. 32, Jun. 2012, doi: 10.15690/pf.v9i3.319.

D. Agrawal, E. M. Shajil, Y. S. Marfatia, and R. Begum, “Study on the Antioxidant Status of Vitiligo Patients of Different Age Groups in Baroda,” Pigment Cell Res, vol. 17, no. 3, pp. 289–294, May 2004, doi: 10.1111/j.1600-0749.2004.00149.x.

J. Corcoran, “Anorexia Nervosa and Bulimia Nervosa,” in Mental Health Treatment for Children and Adolescents, Oxford University Press, 2010, pp. 159–180. doi: 10.1093/acprof:oso/9780195375718.003.0008.

O. O. Andronnikova, “Psychological characteristics of adolescents prone to suicidal behavior,” in General question of world science, in gqws. General question of world science, 2024, pp. 19–25. doi: 10.18411/gqws-01-2024-04.

K. Persaud and P. Hemmer, “The dynamics of fidelity over the time course of long-term memory,” Cogn Psychol, vol. 88, pp. 1–21, Aug. 2016, doi: 10.1016/j.cogpsych.2016.05.003.

I. Rubina, “Legal Regulation of Medical Checkup of Orphaned Children and Children Left Without Parental Care: New Order — Old Problems,” Journal of Russian Law, vol. 27, no. 8, p. 70, 2023, doi: 10.61205/jrp.2023.092.

H. P V, “Rights of Children without Parental Care,” International Journal of Science and Research (IJSR), vol. 13, no. 2, pp. 213–215, Feb. 2024, doi: 10.21275/sr24202053434.

V. K. Abdullaeva, “FEATURES OF PSYCHO-EMOTIONAL CHANGES IN WOMEN DURING PREGNANCY,” Theoretical & Applied Science, vol. 46, no. 02, pp. 122–124, Feb. 2017, doi: 10.15863/tas.2017.02.46.22.

B. Barahona-Corrêa, “The High-Functioning Group: High-Functioning Autism and Asperger Syndrome in Adults,” in Autism Spectrum Disorders in Adults, Springer International Publishing, 2017, pp. 129–178. doi: 10.1007/978-3-319-42713-3_5.

A. Zabotina et al., “Risk for antipsychotic-induced extrapyramidal symptoms: a focus on monoamine receptors on peripheral blood lymphocytes,” European Neuropsychopharmacology, vol. 29, pp. S279–S280, 2019, doi: 10.1016/j.euroneuro.2018.11.441.

J. Mrizak, S. A. M. I. Ouanes, M. Lakhal, R. Y. M. Rafrafi, and Z. El-Hechmi, “EPA-1205 – Remission and recovery in schizophrenia: associated socio-demographic and clinical features,” European Psychiatry, vol. 29, p. 1, 2014, doi: 10.1016/s0924-9338(14)78451-2.

A. Cherniak, “SCHIZOPHRENOMORPHICAL PSYCHOSIS IN THE PERIOD OF TRAUMA: CLINICAL PICTURE AND METHODS,” in SCIENTIFIC PRACTICE: MODERN AND CLASSICAL RESEARCH METHODS, European Scientific Platform, Sep. 2022. doi: 10.36074/logos-16.09.2022.39.